Enlivex (ENLV) Cash & Equivalents (2013 - 2025)

Enlivex's Cash & Equivalents history runs 13 years deep, the most recent figure standing at $1.9 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 42.62% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $1.9 million (down 42.62% YoY), while the FY2025 annual figure was $1.9 million, down 42.62% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $1.9 million, down from $4.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $67.7 million in Q1 2022, with the low at $1.9 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $5.5 million (2021), against an average of $16.1 million.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents surged 433.9% in 2021, then tumbled 96.58% in 2023.
• Enlivex's Cash & Equivalents stood at $7.0 million in 2021, then surged by 65.94% to $11.6 million in 2022, then jumped by 138.34% to $27.7 million in 2023, then slumped by 88.1% to $3.3 million in 2024, then plunged by 42.62% to $1.9 million in 2025.
• Business Quant data shows ENLV's Cash & Equivalents at $1.9 million in Q4 2025, $4.1 million in Q3 2025, and $1.9 million in Q2 2025.